Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, Andre, Reginster, Jean-Yves, ...
BACKGROUND: In recent years, several studies showed increased rates of hyperglycaemia, diabetes, dyslipidemia, metabolic syndrome as well as cardiovascular disease in schizophrenic patients. The...
Wampers, Martien, Van Eyck, Dominique, Hanssens, Linda, Scheen, Andre, ...
OBJECTIVE: To investigate 3-month changes in glucose metabolism in a naturalistic sample of patients with schizophrenia newly started on or switched to specific atypical antipsychotic medication...
Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, Andre, ...
OBJECTIVES: The presence of metabolic abnormalities is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic abnormalities in...
Van Winkel, Ruud, Van Os, Jim, Celic, Ivan, Van Eyck, Dominique, Wampers, Martien, Scheen, André, ...
OBJECTIVE: Unconfounded differences in inherent vulnerability to metabolic disturbance may be hypothesized for different diagnostic groups with severe mental illness. METHOD: A naturalistic cohort of...
Van Winkel, Ruud, De Hert, Marc, Wampers, Martien, Van Eyck, Dominique, Hanssens, Linda, Scheen, André, ...
OBJECTIVE: To investigate 3-month changes in glucose metabolism in a naturalistic sample of patients with schizophrenia newly started on or switched to specific atypical antipsychotic medication...
De Hert, Marc, Schreurs, Vincent, Sweers, Kim, Van Eyck, Dominique, Hanssens, Linda, Sinko, Sebastjan, ...
The presence of the metabolic syndrome (MetS) is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of MetS in patients with schizophrenia at...
Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, André, Reginster, Jean-Yves, ...
BACKGROUND: In recent years, several studies showed increased rates of hyperglycaemia, diabetes, dyslipidemia, metabolic syndrome as well as cardiovascular disease in schizophrenic patients. The...
Van Winkel, Ruud, De Hert, Marc, Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, André, ...
OBJECTIVES: The presence of metabolic abnormalities is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic abnormalities in...
Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, André, Reginster, Jean-Yves, ...
BACKGROUND: In recent years, several studies showed increased rates of hyperglycaemia, diabetes, dyslipidemia, metabolic syndrome as well as cardiovascular disease in schizophrenic patients. The...
A Case Series: Evaluation of the Metabolic Safety of Aripiprazole (2007)
De Hert, Marc, Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, Andre, ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic...
A Case Series: Evaluation of the Metabolic Safety of Aripiprazole (2007)
Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, Andre, ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic...
Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia (2007)
Kalnicka, Dita, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, ...
Mortality rates in patients with schizophrenia are double compared with the general population, with cardiovascular disease causing 50% of the excess. Lowering low-density lipoprotein cholesterol is...
Kalnicka, Dita, Van Winkel, Ruud, Wampers, Martien, Hanssens, Linda, Van Eyck, Dominique, ...
BACKGROUND: Mortality rates in patients with schizophrenia are double compared to those in the general population, with cardiovascular disease causing 50% of the excess. Lowering low-density...
Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE(R) (2006)
Peuskens, Bie, Van Winkel, Ruud, Kalnicka, Dita, Hanssens, Linda, Van Eyck, Dominique, ...
BACKGROUND: Metabolic abnormalities and weight gain are an important problem in patients with schizophrenia. An instrument to evaluate body image and self-esteem related to weight has recently been...
Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, Andre, ...
OBJECTIVE: To assess the diagnostic properties of 2 different screening guidelines for the detection of diabetes in patients diagnosed with schizophrenia. METHOD: Over a 2-year period (November...
Van Eyck, Dominique, Hanssens, Linda, Peuskens, Hendrik, Thys, Erik, Wampers, Martien, ...
OBJECTIVE: A recent consensus conference has proposed guidelines for the monitoring for diabetes in patients with schizophrenia and also identifies the need of long-term prospective studies. METHOD:...
De Hert, Marc, Van Eyck, Dominique, Hanssens, Linda, Peuskens, Hendrik, Thys, Erik, Wampers, Martien, ...
Objective. - A recent consensus conference has proposed guidelines for the monitoring for diabetes in patients with schizophrenia and also identifies the need of long-term prospective studies....
De Hert, Marc A., Van Winkel, Ruud, Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, André, ...
The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic syndrome in European patients...
Van Winkel, Ruud, Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, Andre, ...
The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic syndrome in European patients...
Van Eyck, Dominique, De Nayer, Andre
Epidemiological studies have demonstrated a relevant increased risk of diabetes in schizophrenic patients who are treated with many atypical antipsychotics, irrespective of concomitant weight gain....
De Hert, Marc, Kalnicka, Dita, Van Winkel, Ruud, Wampers, Martien, Hanssens, Linda, Van Eyck, Dominique, ...
BACKGROUND: Mortality rates in patients with schizophrenia are double compared to those in the general population, with cardiovascular disease causing 50% of the excess. Lowering low-density...
Van Winkel, Ruud, De Hert, Marc, Van Eyck, Dominique, Hanssens, Linda, Wampers, Martien, Scheen, André, ...
OBJECTIVE: To assess the diagnostic properties of 2 different screening guidelines for the detection of diabetes in patients diagnosed with schizophrenia. METHOD: Over a 2-year period (November...
Hanssens, Linda, De Hert, Marc, Van Eyck, Dominique, Wampers, Martien, Scheen, André, Peuskens, Joseph
A Case Series: Evaluation of the Metabolic Safety of Aripiprazole (2006)
De Hert, Marc, Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, Andre, ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic...
Oral glucose tolerance tests in schizophrenic patients treated with antipsychotics (2004)
De Hert, Marc, Van Eyck, Dominique, Hermans, Gilberte, Peuskens, Hendrik, Wampers, Martien, De Patoul, A, ...
Objective. –A recent consensus conference has proposed guidelines for the monitoring for diabetes in patients with schizophrenia and also identifies the need of long-term prospective studies....
A Case Series: Evaluation of the Metabolic Safety of Aripiprazole
De Hert, Marc, Hanssens, Linda, Van Winkel, Ruud, Wampers, Martien, Van Eyck, Dominique, Scheen, Andre, ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic...